Lonza Group Ownership

LONN Stock  CHF 590.80  11.80  2.04%   
Lonza Group AG maintains a total of 74.19 Million outstanding shares. Over half of Lonza Group's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Lonza Group AG. Please watch out for any change in the institutional holdings of Lonza Group AG as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lonza Group AG. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.

Lonza Stock Ownership Analysis

About 53.0% of the company shares are owned by institutional investors. The book value of Lonza Group was now reported as 142.97. The company has Price/Earnings To Growth (PEG) ratio of 1.53. Lonza Group AG recorded earning per share (EPS) of 12.22. The entity last dividend was issued on the 9th of May 2023. The firm had 407:377 split on the 2nd of May 2017. Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia and New Zealand, and internationally. The company was founded in 1897 and is headquartered in Basel, Switzerland. LONZA N operates under Diagnostics Research classification in Switzerland and is traded on Switzerland Exchange. It employs 17154 people. To find out more about Lonza Group AG contact the company at 41 61 316 81 11 or learn more at https://www.lonza.com.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lonza Stock Analysis

When running Lonza Group's price analysis, check to measure Lonza Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lonza Group is operating at the current time. Most of Lonza Group's value examination focuses on studying past and present price action to predict the probability of Lonza Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lonza Group's price. Additionally, you may evaluate how the addition of Lonza Group to your portfolios can decrease your overall portfolio volatility.